Delayed neurotoxic complication of intracavitary bleomycin therapy for craniopharyngioma in a child who had previously undergone radiosurgery
Authors:
- Deniz BelenDBDeniz Belen
- Uygur ErUEUygur Er
- Kazim YigitkanliKYKazim Yigitkanli
- Hayrunnisa BolayHBHayrunnisa Bolay
- 1 May 2007
- journal article
- case report
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of neurosurgery. Pediatrics
- Vol. 106 (5) , 391-393
Abstract
Local administration of bleomycin for the treatment of craniopharyngioma is occasionally associated with serious regional complications. The authors report a case of a delayed neurotoxic complication associated with bleomycin treatment in a patient who had previously undergone radiosurgery. A 14-year-old boy presented with a cyst recurrence of mixed-type craniopharyngioma. An Ommaya device was placed in the thin-walled cyst, and after confirmation that the device was watertight, the patient received a total dose of 75 mg bleomycin intratumorally during a 5-week period. Six weeks after the final drug administration, the patient experienced complex partial epileptic seizures; a few days later sudden right temporal hemianopia developed. Within 5 days the patient became totally blind in his right eye, and the condition did not respond to corticosteroid therapy. Although drug-related toxic complications occur commonly during the course of intracavitary bleomycin treatment, they may also be encountered during the follow-up period. The reason for this delayed complication could have been previous radiotherapy or hypersensitivity of the tumor capsule to the drug.Keywords
This publication has 12 references indexed in Scilit:
- Intracavitary therapeutic options in the management of cystic craniopharyngiomaChild's Nervous System, 2005
- Craniopharyngiomas: our experience in LyonChild's Nervous System, 2005
- Radiation therapy in the management of pediatric craniopharyngiomas—a reviewChild's Nervous System, 2005
- Individualized treatment of craniopharyngioma in children: ways and meansChild's Nervous System, 2005
- Long-term outcome and reconsideration of intracystic chemotherapy with bleomycin for craniopharyngioma in childrenChild's Nervous System, 2005
- Phase II evaluation of interferon α-2a for progressive or recurrent craniopharyngiomasJournal of Neurosurgery, 2000
- Fatal Toxic Effect of Bleomycin on Brain Tissue after Intracystic Chemotherapy for a Craniopharyngioma: Case ReportNeurosurgery, 2000
- Use of bleomycin in intratumoral chemotherapy for cystic craniopharyngiomaJournal of Neurosurgery, 1996
- Toxic effects of bleomycin on the hypothalamus following its administration into a cystic craniopharyngiomaBritish Journal Of Neurosurgery, 1994
- Evaluation of postoperative intratumoral injection of bleomycin for craniopharyngioma in childrenJournal of Neurosurgery, 1985